Search
for
Sort by
Research 421–450 of 1000+
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- Common Dermatologic Conditions
- Antiandrogen therapy for androgenetic alopecia
- Biology of Human Hair: Know Your Hair to Control It
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Hair loss
- Ocular Cosmetics in Modern Times
- Integral Roles of Specific Proteoglycans in Hair Growth and Hair Loss: Mechanisms behind the Bioactivity of Proteoglycan Replacement Therapy with Nourkrin® with Marilex® in Pattern Hair Loss and Telogen Effluvium
- Transfollicular drug delivery: current perspectives
- The eye and the skin in endocrine metabolic diseases
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Prevention of Alopecia in Medical and Interventional Chemotherapy Patients
- LETTERS TO THE EDITOR
- Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing?
- Novel therapies for alopecia areata: The era of rational drug development
- CUTANEOUS MASTOCYTOSIS IN CHILDREN: AN INDIAN EXPERIENCE
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Chapter 20. Pathogenesis and Treatment of Alopecias
- Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris
- An overview of management of drug-induced hair and nail disorders
- Biology of the skin and dermatological disease
- Stress, Hair Growth Control, and the Neuro-Endocrine-Immune Connection
- A Case Report of Cushing’s Disease Presenting as Hair Loss
- Both low circulating insulin-like growth factor-1 and high-density lipoprotein cholesterol are associated with hair loss in middle-aged women
- Acne in Dark Skin
- Hair Follicle Targeting with Nanoparticles
- Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS—A prospective study
- Alopecia areata; combination therapy with isotretinoin (0.05%) gel and minoxidil (2%) solution
- Skin manifestations of endocrine diseases